ALLENSPACH,K.,GASCHEN,F.(2003):
Chronische Darmerkrankungen beim Hund: Eine Übersicht.
Schweiz. Arch. Tierheilkd., 145, 209-222.
ALLENSPACH, K., LUCKSCHANDER, N., STYNER, M., SEIBOLD, F., DOHERR, M., AESCHBACH, D., GASCHEN, F., (2004):
Evaluation of assays for perinuclear antineutrophilic cytoplasmic antibodies and antibodies to Saccharomyces cerevisiae in dogs with inflammatory bowel disease.
Am. J. Vet. Res., 65, 1279-1283.
ALLENSPACH, K., BERGMAN, P. J., SAUTER, S., GRÖNE, A., DOHERR, M. G., GASCHEN, F. (2006):
P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopathic enteropathies.
J. Comp. Pathol., 134, 1-7.
ALLENSPACH, K., WIELAND, B., GRÖNE, A., GASCHEN, F. (2007):
Chronic enteropathies in dogs: evaluation of risk factors for negative outcome.
J. Vet. Intern. Med., 21, 700-708.
ALLENSPACH, K., LOMAS, B., WIELAND, B., HARRIS, T., PRESSLER, B., MANCHO, C., LEES, G. E., VADEN, S. L. (2008):
Evaluation of perinuclear anti-neutrophilic cytoplasmic autoantibodies as an early marker of protein-losing enteropathy and protein-losing nephropathy in Soft Coated Wheaten Terriers.
Am. J. Vet. Res., 69, 1301- 1304.
ALLENSPACH, K., HOUSE, A., SMITH, K., MCNEILL, F. M., HENDRICKS, A., ELSON-RIGGINS, J., RIDDLE, A., STEINER, J. M., WERLING, D., GARDEN, O. A., CATCHPOLE, B., SUCHODOLSKI, J. S. (2010):
Evaluation of mucosal bacteria and histopathology, clinical disease activity and expression of Toll-like receptors in German shepherd dogs with chronic
enteropathies.
Vet. Microbiol., 146, 326-335.
ALLENSPACH, K. (2011):
Clinical immunology and immunopathology of the canine and feline intestine.
Vet. Clin. North Am. Small Anim. Pract., 41, 345-60.
BANKS, W. J. (1993):
Applied Veterinary Histology, 3. Edition, Mosby-Year Book, S. 346-353.
BARTA, O., BREITSCHWERDT, E. B., SHAFFER, L. M., POURCIAU, S. S. (1983):
Lymphocte transformation and humoral immune factors in Basenji dogs with immunoproliferative small intestinal disease.
Am. J. Vet. Res., 44, 1954-1959.
BECKMANN, J. S., KOPPENOL, W. H. (1996):
Nitric oxide, superoxide, and peroxynitrite: the good, the bad and the ugly.
Am. J. Physiol. 271, 1424-1437.
BISCHOFF, S. C., WEDEMEYER, J., HERRMANN, A., MEIER, P. N., TRAUTWEIN, C., CETIN, Y., MASCHEK, H., STOLTE, M., GEBEL, M., MANNS, M. P. (1996):
Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease.
Histopathology, 28, 1-13.
BOGDAN, C., RÖLLINGHOF, M., DIEFENBACH, A. (2000):
The role of nitric oxide in innate immunity.
Immunol. Rev., 173, 17-26.
BOGDAN, C. (2001):
Nitric oxid and the immune response.
Nat. Immunol., 2, 907-916.
BOUGHTON-SMITH, N. K., EVANS, S. M., HAWKEY, C. J., COLE, A. T., BALSITIS, M., WHITTLE, B. J. R., MONCADA, S. (1993):
Nitric oxide synthase activity in ulcerative colitis and Crohn`s disease.
Lancet, 342, 338-340.
BRANDTZAEG, P., VALNES, K., SCOTT, H., ROGNUM, T. O., BJERKE, K., BAKLIEN, K. (1985):
The human gastrointestinal secretory immune system in health and disease.
Scand. J. Gastroenterol. Suppl., 114, 17-38.
BRANDTZAEG, P. (2009):
Mucosal immunity: induction, dissemination, and effector functions.
Scand. J. Immunol., 70, 505-515.
BREITSCHWERDT, E. B., OCHOA, R., BARTA, M., BARTA, O., MCCLURE, J., WALTMAN, C. (1983):
Clinical and laboratory characterization of Basenjis with immunoproliferative small intestinal disease.
Am. J. Vet. Res., 45, 267-273.
Literaturverzeichnis 103
BRELLOU, G. D., KLEINSCHMIDT, S., MENESES, F., NOLTE, I., HEWICKER-TRAUTWEIN, M. (2006):
Eosinophilic granulomatous gastroenterocolitis an dhepatitis in a 1-year-old male Siberian Husky.
Vet. Pathol., 43, 1022-1025.
BRIGHT, R. M., JENKINS, C., DENOVO, R., MCCRACKIN, M. A., TOAL, R. (1994):
Chronic diarrhoe in a dog with regional granulomatous enteritis.
J. Small Anim. Pract., 35, 423-426.
BULTINCK, J., SIPS, P., VAKAET, L., BROUCKAERT, P., CAUWELS, A. (2006):
Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo expression pattern in (septic) shock.
The FASEB Journal, 20, E1619-E1627.
BURGENER, I. A., KÖNIG, A., ALLENSPACH, K., SAUTER, S. N., BOISCLAIR, J., DOHERR, M. G., JUNGI, T. W. (2008):
Upregulation of toll-like receptors in chronic enteropathies in dogs.
J. Vet. Intern. Med., 22, 553-560.
CAVE, N. J. (2003):
Chronic inflammatory disorders of the gastrointestinal tract of companion animals.
N. Z. Vet. J., 51, 262-274.
CASAMIAN-SORROSAL, D., WILLARD, M. D., MURRAY, J. K., HALL, E. J., TAYLOR, S. S., DAY, M. J. (2010):
Comparison of histopathologic findings in biopsies from the duodenum and ileum of dogs with enteropathy.
J. Vet. Intern. Med., 24, 80-83.
CORTINA, G., SMART, C. N., FARMER, D. G., BHUTA, S., TREEM, W. R., HILL, I.
D., MARTÍN, M. G. (2007):
Enteroendocrine cell dysgenesis and malabsorption, a histopathologic and immunohistochemical characterization.
Hum. Pathol., 38, 570-580.
CRAVEN, M., SIMPSON, J. W., RIDYARD, A. E., CHANDLER, M.L. (2004):
Canine inflammatory bowel disease: retrospective analysis of diagnosis and outcome in 80 cases (1995-2002).
J. Small Anim. Pract., 45, 336-342.
CRAVEN, M., ACLAND, G. M., MEZEY, J., BOYKO, A., WANG, W., MEURS, K., MCDONOUGH, S., SIMPSON, K. W. (2010):
Genome-wide association scan reveals polymorphisms in the p67phox subunit (Ncf2) of the NADPH oxidase complex in boxer dogs with adherent and invasive E. coli- associated granulomatous colitis: A potential model of chronic granulomatous disease.
Gastroenterology, 138, 683.
DANDRIEUX,J.R.,BORNAND,V.F.,DOHERR,M.G.,KANO,R.,ZURBRIGGEN, A.,BURGENER,I.A.(2008):
Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease.
Am. J. Vet. Res., 69, 1279-1285
DAY, M. J., T. BILZER, J. MANSELL, B. WILCOCK, E. J. HALL, A. JERGENS, T.
NINAMI, M. WILLARD u. R. WASHABAU (2008):
Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the world small animal veterinary association gastrointestinal standardization group.
J. Com. Pathol., 138, 1-43.
DE ABREU VIEIRA, P.M., FORTES FRANCISCO, A., MARTINS DE SOUZA, S., MALAQUIAS, L.C.C., BARBOSA REIS, A., CORDEIRO GUINCHETTI, R., VELOSO, V.M., DE LANA, M., TAFURI, W.L., MARTINS CARNEIRO, C. (2009):
Trypanosoma cruzi: Serum levels of nitric oxide and expression of inducible nitric oxide synthase in myocardium and spleen of dogs in the acute stage of infection with metcyclic or blood trypomastigotes.
Exp. Parasit., 121, 76-82.
DE BUYSSCHER, E. V., BREITSCHWERDT, E. B., MACLACHLAN, N. J. (1988):
Elevated serum IgA associated with immunoproliferative enteropathy of Basenji dogs: Lack of evidence for alpha heavy-chain disease or enhanced intestinal IgA secretion.
Vet. Immunol. Immunopathol., 20, 41-52.
DE MAJO, M., PUGLIESE, M., GALIA, S., MAZZULLO, G., LA CAMERA, E., FERA, M. T. (2008):
Cytokine mRNA quantification in gastro-intestinal biopsies of dogs with idiopathic chronic enteropathies by real time RT-PCR: preliminary results.
Vet. Res. Commun., 32, 275-277.
DIBARTOLA, S. P., ROGERS, W. A., BOYCE, J. T., GRIMM, J. P., (1982):
Regional enteritis in two dogs.
J. Am. Vet. Med. Assoc., 181, 904-908.
Literaturverzeichnis 105
DIJKSTRA, G., MOSHAGE, H., VAN DULLEMEN, H. M., DE JAGER-KRIKKEN, A., TIEBOSCH, A., KLEIBEUKER, J. H., JANSEN, P., VAN GOOR, H. (1998):
Expression of nitric oxide synthases and formation of nitrotyrosine and reactive oxygen species in inflammatory bowel disease.
J. Pathol., 186, 416-421.
DIJKSTRA, G., ZANDVOORT, A. J., KOBOLD, A. C., DE JAGER-KRIKKEN, A., HEERINGA, P., et al. (2002):
Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease.
Scand. J. Gastroenterol., 37, 546-554.
EISERICH, J. P., HRISTOVA, M., CROSS, C. E., et al. (1998):
Formation of nitricoxide-derived inflammatory oxidants by myeloperoxidase in neutrophils.
Nature, 391, 393-397.
FLESJA, K., YRI, T. (1977):
Protein-losing enteropathy in the Lundehund.
J. Small Anim. Pract., 18, 11-23.
FOSTER, A. P., KNOWLES, T. G., MOORE, A. H., COUSINS, P. D. G., DAY, M. J., HALL, E. J. (2003):
Serum IgE and IgG responses to food antigens in normal and atopic dogs, and dogs with gastrointestinal disease.
Vet. Immunol. Immunopathol., 92, 113-124.
FUSS, I. J. (2008):
Is the Th1/Th2 paradigm of immune regulation applicable to IBD?
Inflamm. Bowel Dis., 14, S110-S112.
GAJEWSKI, T.F., FITCH, F.W. (1988):
Anti-proliferative effect of IFN-γ in immune regulation. INF-γ inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.
J. Immunol., 15, 4245-4252.
GERMAN, A. J., HALL, E. J., KELLY, D. F., WATSON, A. D. J., DAY, M. J. (2000a):
An Immunohistochemical study of histiocytic ulcerative colitis in boxer dogs.
J. Comp. Pathol., 122, 163-175.
GERMAN, A. J., HELPS, C. R., HALL, E. J., DAY, M. J. (2000b):
Cytokine mRNA expression in mucosal biopsies from german shepherd dogs with small intestinal enteropathies.
Dig. Dis. Sci., 45, 7-17.
GERMAN, A. J., HALL, E. J., DAY, M. J. (2001):
Immune cell popluations within the duodenal mucosa of dogs with enteropathies.
J. Vet. Intern. Med., 15, 14-25.
GERMAN, A. J., DAY, M. J., RUAUX, C. G., STEINER, J. M., WILLIAMS, D. A., HALL, E. J. (2003a):
Comparison of direct and indirect tests for small intestinal bacterial overgrowth and antibiotic-responsive diarrhea in dogs.
J. Vet. Intern. Med., 17, 33-43.
GERMAN, A. J., HALL, E. J., DAY, M. J. (2003b):
Chronic intestinal inflammation and intestinal disease in dogs.
J. Vet. Intern. Med., 17, 8-20.
GOMEZ, J. A., RUSSELL, S. W., TROWBRIDGE, J. O., LEE, J. (1977):
Canine histiocytic ulcerative colitis - an ultrastructural study of the early mucosal lesion.
Dig. Dis., 22, 485-496.
GUIHOT, G., GUIMBAUD, R., BERTRAND, V., NARCY-LAMBARE, B., COUTURIER, D., DUÉE, P. H., CHAUSSADE, S., BLACHIER, F. (2000):
Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas:
correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn`s disease.
Amino Acids, 18, 229-237.
GUILFORD, W.G. (1996):
Idiopathic inflammatory bowel diseases.
In: W.G. Guilford (Hrsg.): Strombeck`s Small Animal Gastroenterology. 3. Auflage W.B. Saunders, Philadelphia, S. 451-486.
GUNAWARDANA, S.C., JERGENS, A.E., AHRENS, F.A., NIYO, Y. (1997):
Colonic nitrite and immunoglobulin G concentration in dogs with inflammatory bowel disease.
J. Am. Vet. Med. Assoc., 211, 318-321.
HALL, E.J., SIMPSON, K.W. (2000):
Diseases of the small intestine.
In: S.J. Ettinger und E.C. Feldmann (Hrsg.): Textbook of Veterinary Internal Medicine. 5. Aufl.
W.B. Saunders, Philadelphia, S. 1182-1238.
HALLIWELL, B. (1996):
Antioxidants in human health and disease.
Annu. Rev. Nutr., 16, 33-50.
HAYDEN, D.W., VAN KRUININGEN, H.J. (1973):
Eosinophilic gastroenteritis in German shepherd dogs and its relationship to visceral larva migrans.
J. Am. Med. Assoc., 162, 379-384.
Literaturverzeichnis 107
HOSTUTLER, R. A., LURIA, B. J., JOHNSON, S. E., WEISBRODE, S. E., SHERDING, R. G., JAEGER, J. Q., GUILFORD, W. G. (2004):
Antibiotic-responsive histiocytic ulcerative colitis in 9 dogs.
J. Vet. Intern. Med., 18, 499-504.
HUANG, F. P., NIEDBALA, W., WIE, X. Q., XU, D., FENG, G. J., ROBINSON, J. H., LAM, C., LIEW, F. Y. (1998):
Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages.
Eur. J. Immunol., 28, 4062-4070.
IKEDA, K., MATSUMI, S., MAGARA, T., NAKAGAWA, S. (1995):
Purification and characterization of canine manganese superoxide dismutase and immunohistochemical localization in canine heart compared with that of copper-zinc superoxide dismutase.
Int. J. Biochem. Cell Biol., 27, 1257-1265.
JACOBS, G., COLLINS-KELLY, L., LAPPIN, M., TYLER, D. (1990):
Lymphocytic-plasmacytic enteritis in 24 dogs.
J. Vet. Intern. Med., 4, 45-53.
JERGENS, A. E., MOORE, F.M., HAYNES, J.S., MILES, K.G (1992):
Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990).
J. Am. Vet. Med. Assoc., 201, 1603-1608.
JERGENS, A. E., CARPENTER, S. L., WANNEMUEHLER, Y., AHRENS, F. A.
(1998):
Molecular detection of inducible nitric oxide synthase in canine inflammatory bowel disease.
J. Vet. Intern. Med., 12, 205.
JERGENS, A. E. (1999):
Inflammatory bowel diesease. Current perspectives.
Vet. Clin. North Am. Small Anim. Pract., 29, 501-521.
JERGENS, A. E., GAMET, Y., Moore, F. M., NIYO, Y., TSAO, C., SMITH, B. (1999):
Colonic lymphocyte and plasma cell populations in dogs with lymphocytic-plasmacytic colitis.
Am. J. Vet. Res., 60, 515-20.
JERGENS, A. E., WILLARD, M. D. (2000):
Diseases of the large intestine.
In: S.J. Ettinger und E.C. Feldmann (Hrsg.): Textbook of Veterinary Internal Medicine. 5. Aufl.
W.B. Saunders, Philadelphia, S.1238-1256.
JERGENS, A. E., SCHREINER, C. A., FRANK, D. E., NIYO, Y., AHRENS, F. E., ECKERSALL, P. D., BENSON, T. J., EVANS, R. (2003):
A scoring index for disease activity in canine inflammatory bowel disease.
J. Vet. Intern. Med., 17, 291-297.
JERGENS, A. E., SONEA, I. M., O´CONNOR, A. M., KAUFFMAN, L, K., GROZDANIC, S., D., ACKERMANN, M. R., EVANS, R. B. (2009a):
Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal.
Comp. Med., 59, 153-162.
JERGENS, A. E., CRANDELL, J., MORRISON, J. A., DEITZ, K., PRESSEL, M., ACKERMANN, M., SUCHODOLSKI, J. S., STEINER, J. M., EVANS, R. (2009b):
Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial.
J. Vet. Intern. Med., 24, 269-277.
JERGENS, A. E., NETTLETON, D., SUCHODOLSKI, J. S., WYMORE, M., WILKE, V., DOWD, S., STEINER, J. M., WANG, C., WANNEMUEHLER, M. J. (2010):
Relationship of mucosal gene expression to microbiota composition in dogs with inflammatory bowel disease.
J. Vet. Intern. Med., 24, 725.
JERGENS, A. E., SIMPSON, K. W. (2012):
Inflammatory bowel disease in veterinary medicine.
Frontiers in Bioscience, E4, 1404-1419.
JOHNSON, S. E. (1992):
Canine eosinophilic gastroenterocolitis.
Semin. Vet. Med. Surg. Small Anim., 7, 145-152.
JUNGINGER, J., SCHWITTLICK, U., LEMENSIECK, F., NOLTE, I., HEWICKER-TRAUTWEIN, M. (2012):
Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs.
Vet. Res., 43:23.
KATHRANI, A., HOUSE, A., WERLING, D., CATCHPOLE, B., MURPHY, A., GERMAN, A. J., LEE, H., ALLENSPACH, K. (2010a):
Overdominant single nucleotide polymorphisms in the nucleotide oligomerisation domain two (NOD2) Gene are significantly associated with canine inflammatory bowel disease.
Gastroenterology, 138, 725.
Literaturverzeichnis 109
KATHRANI, A., HOUSE, A., CATCHPOLE, B., MURPHY, A., GERMAN, A. J., WERLING, D., ALLENSPACH, K. (2010b):
Polymorphisms in the TLR4 and TLR5 gene are significantly associated with inflammatory bowel disease in german shepherd dogs.
Plos One, 5, 15740.
KATHRANI, A., WERLING, D., ALLENSPACH, K. (2011a):
Canine breeds at high risk of developing inflammatory bowel disease in the south-eastern UK.
Vet. Rec., 169, 635.
KATHRANI, A., SCHMITZ, S., PRIESTNALL, S. L., SMITH, K. C., WERLING, D., GARDEN, O. A., ALLENSPACH, K. (2011b):
CD11c+ cells are significantly decreased in the duodenum, ileum and colon of dogs with inflammatory bowel disease.
J. Comp. Pathol., 145, 359-366.
KIMURA, H., HOKARI, R., MIURA, S., SHIGEMATSU, T., HIROKAWA, M., AKIBA, Y., KUROSE, I., HIGUCHI, H. FUJIMORI, H., TSUZUKI, Y., SERIZAWA, H., ISHII, H.
(1998):
Increased expression of an inducible isoform of nitric oxide synthase and the
formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis.
Gut, 42, 180-187.
KLEINSCHMIDT, S., MENESES, F., NOLTE, I., HEWICKER-TRAUTWEIN, M.
(2007):
Characterization of mast cell numbers and subtypes in biopsies from the gastrointestinal tract of dogs with lymphocytic-plasmacytic or eosinophilic gastroenterocolitis.
Vet. Immunol. Immunopathol., 120, 80-92.
KLEINSCHMIDT, S., NOLTE, I., HEWICKER-TRAUTWEIN, M. (2011):
Structural and functional components of the feline enteric nervous system in healthy cats and in cats with chronic inflammatory and non-inflammatory diseases of the gastrointestinal tract.
Res. Vet. Sci., 91, 129-135.
KNOWLES, R. G., MONCADA, S. (1994):
Nitric oxide synthases in mammals.
Biochem. J., 298, 249-258.
KOLBJORNSEN, O., PRESS, C. M., LANDSVERK, T. (1994):
Gastropathies in the Lundehund. I. Gastritis and gastric neoplasia associated with intestinal lymphangiectasia.
APMIS, 102, 647-661.
KOLIOS, G., ROONEY, N., MURPHY, C. T., ROBERTSON, D. A. F., WESWICK, J.
(1998):
Expression of inducible nitric oxide synthase activity in human colon epithelial cells:
modulation by T-lymphocyte derived cytokines.
Gut, 43, 56-63.
KOLIOS, G., VALATAS, V., WARD, S. G. (2004):
Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle.
Immunology, 113, 427-437.
KRUIDENIER, L., VERSPAGET, H. W. (2002):
Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease – radicals or ridiculous?
Aliment. Pharmacol., 16, 1997-2015.
KRUIDENIER, L., KUIPER, I., VAN DUIJN, W., MARKLUND, S. L.,VAN HOGEZAND, R. A., LAMERS, C., VERSPAGET, H. W. (2003a):
Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
J. Pathol., 201, 7-16.
KRUIDENIER, L., KUIPER, I., VAN DUIJN, W., MARKLUND, S. L.,VAN HOGEZAND, R. A., LAMERS, C., VERSPAGET, H. W. (2003b):
Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
J. Pathol., 201, 17-27.
KRUIDENIER, L., KUIPER, I., VAN DUIJN, W., MARKLUND, S. L.,VAN HOGEZAND, R. A., LAMERS, C., VERSPAGET, H. W. (2003c):
Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
J. Pathol., 201, 28-36.
KUBES, P., MCCAFFERTY, D.-M. (2000):
Nitric oxide and intestinal inflammation.
Am. J. Med., 109, 150-158.
LANDSVERK, T., GAMLEM, H. (1984):
Intestinal lymphangiectasia in the Lundehund. Scanning electron microscopy of intestinal mucusa.
Acta Pathol. Microbiol. Immunol. Scand A., 92, 353-362.
LANGRISH, C.L., CHEN, Y., BLUMENSCHEIN, W.M., MATTSON, J., BAHAM, B., SEDWICK, J.D. (2005):
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation.
J. Exp. Med., 201, 233-40.
Literaturverzeichnis 111
LEWIS, D. C. (1995):
Successful treatment of regional enteritis in a dog.
J. Am. Anim. Hosp. Assoc., 31, 170-173.
LI, Y., HUANG, T. T., CARLSON, E. J., et al. (1995):
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase.
Nat. Genet., 11, 376-381.
LIEBICH, H.-G. (1993):
Verdauungsapparat (Apparatus digestorius).
In: H.-G. Liebich (Hrsg): Funktionelle Histologie: Farbatlas und Kurzlehrbuch der mikroskopischen Anatomie der Haussäugetiere. 2. Aufl.
Schattauer, Stuttgart, S. 165-193.
LITTMANN, M. P., DAMBACH, D. M., VADEN, S. L., GIGER, U. (2000):
Familial protein-losing enteropathy and protein-losing nephropathy in soft coated Wheaten Terriers: 222 cases (1983-1997).
J. Vet. Intern. Med., 14, 60-80.
LOCHER, C., TIPOLD, A., WELLE, M., BUSATO, A., ZURBRIGGEN, A., GRIOT-WENK, M. E. (2001):
Quantitative assessment of mast cells and expression of IgE protein and mRNA for IgE and interleukin 4 in the gastrointestinal tract of healthy dogs and dogs with inflammatory bowel disease.
Am. J. Vet. Res., 62, 211-216.
LUCKSCHANDER, N., ALLENSPACH, K., HALL, J., SEIBOLD, F., GRÖNE, A., DOHERR, M. G., GASCHEN, F. (2006):
Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diareic dogs with food responsive disease or inflammatory bowel disease.
J. Vet. Intern. Med., 20, 221-227.
LUCKSCHANDEER, N., HALL, J. A., GASCHEN, F., FORSTER, U., WENZLOW, N., HERMANN, P., ALLENSPACH, K., DOBBELAERE, D., BURGENER, I. A., WELLE, M. (2010):
Activation of nuclear factor-κB in dogs with chronic enteropathies.
Vet. Immunol. Immunopathol., 133, 228-236.
LUNDBERG, J. O., HELLSTROM, P. M., LUNDBERG, J. M., ALVING, K. (1994):
Greatly increased luminal nitric oxide synthesis in ulcerative colitis.
Lancet, 344, 1673-1674.
MAEDA, S., OHNO, K., NAKAMURA, K., UCHIDA, K., NAKASHIMA, K., FUKUSHIMA, K., TSUKAMOTO, A., GOTO-KOSHINO, Y., FUJINO, Y., TSUJIMOTO, H. (2011):
Quantification of chemokine and chemokine receptor gene expression in duodenal mucosa of dogs with inflammatory bowel disease.
Vet. Immunol. Immunopathol., 144, 290-298.
MAEDA, S., OHNO, K., NAKAMURA, K., UCHIDA, K., NAKASHIMA, K.,
FUKUSHIMA, K., TSUKAMOTO, A., GOTO-KOSHINO, Y., FUJINO, Y, TSUJIMOTO, H. (2012):
Mucosal imbalance of interleukin-1 β and interleukin-1 receptor antagonist in canine inflammatory bowel disease.
Vet. J., http://dx.doi.ogr/10.1016/j.tvjl.2012.02.026
MANCHO, C., SAINZ, Á., GARCÍA-SANCHO, M. VILLAESCUSA, A., TESOURO, M.
A., RODRÍGEZ-FRANCO, F. (2010):
Detection of perinuclear antineutrophil cytoplasmic antibodies and antinuclear antibodies in the diagnosis of canine inflammatory bowel disease.
J. Vet. Diagn. Invest., 22, 553-558.
MANDIGER, P. J. J., BIORUGE, V., VAN DEN INGH, T. S. G. A. M., ANKRINGA, N., GERMAN, A. J. (2010):
A randomized, open-label, positively-controlled field trial of a hydrolyzed protein diet in dogs with chronic small bowel enteropathy.
J. Vet. Intern. Med., 24, 1350-1357.
MANSFIELD, C. S., JAMES, F. E., CRAVEN, M., DAVIES, D. R., O´HARA, A. J., NICHOLLS, P. K., DOGAN, B., MACDONOUGH, S. P., SIMPSON, K. W. (2009):
Remission of histiocytic ulcerative colitis in Boxer dogs correlates with eradication of invasive intramucosal Escherichia coli.
J. Vet. Intern. Med., 23, 964-969.
MARKLUND, S. L. (1984):
Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species.
Biochem. J., 222, 649-655.
MARKS, S.L., LAFLAMME, D.P., MCALOOSE, D. (2002):
Dietary trial using a commercial hypoallergenic diet containing hydrolyzed protein for dogs with inflammatory bowel disease.
Vet. Ther., 3, 109-118.
MCCAFFERTY, D. M., MUDGETT, J. S., SWAIN, M. G., KUBES, P. (1997):
Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation.
Gastroenterology, 112, 1022-1027.
Literaturverzeichnis 113
MCCAFFERTY, D. M. (2000):
Peroxynitrite and inflammatory bowel disease.
Gut, 46, 436-439.
MCCAFFERTY, D.M., SIHOTA, E., MUSCARA, M., WALLACE, J. L., SHARKEY, K.
A., KUBES, P. (2000):
Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice.
Am. J. Physiol. Gastrointest. Liver Physiol., 279, G90-G99.
MCCANN, T. M., RIDYARD, A. E., ELSE, R. W., SIMPSON, J. W. (2007):
Evalution of disease activity markers in dogs with idiopathic inflammatory bowel disease.
J. Small. Anim. Pract., 48, 620-625.
MCCORD, J. M., FRIDOVICH, I. (1969):
Superoxide dismutase: an enzymatic function for erythrocuprein (hemocuprein).
J. Biol. Chem., 244, 6049-6055.
MCLACHLAN, N. J., BREITSCHWERDT, E. B., CHAMBERS, J. M., ARGENZIO, R.
A., DE BUYSSCHER, E. V. (1988):
Gastroenteritis of Basenji dogs.
Vet. Pathol., 25, 36-41.
MCMAHON, L. A., HOUSE, A. K., CATCHPOLE, B., ELSON-RIGGINS, J., RIDDLE, A., SMITH, K., WERLING, D., BURGENER, I. A., ALLENSPACH, K. (2010):
Expression of toll-like receptor 2 in duodenal biopsies from dogs with inflammatory bowel disease is associated with severity of disease.
Vet. Immunol. Immunopathol., 135, 158-163.
MIDDLETON, S. J., SHORTHOUSE, M., HUNTER, J. O. (1993):
Increased nitric oxide synthesis in ulcerative colitis.
Lancet, 341, 465-466.
MILLER, M. J. S., SADOWSKA-KROWICKA, H., CHOTINARUEMOL, S., et al.
(1992):
Amelioration of chronic ileitis by nitric oxide synthase inhibition.
J. Pharmacol. Exp. Ther., 264, 11-16.
MILLER, M. J. S., THOMPSON, J. H., ZHANG, X. J., SADOWSKA-KROWICKA, H., KAKKIS, J. L., MUNSHI, U. K., SANDOVAL, M., ROSSI, J. L., ELOBY, S.,
BECKMAN, J. S., YE, Y. Z., RODI, C. P., MANNING, P. T., CURRIE, M. G., CLARK, D. A. (1995):
Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis.
Gastroenterology, 109, 1475-1483.
MODOLELL, M., CORRALIZA, I. M., LINK, F., SOLER, G., EICHMANN, K. (1995):
Reciprocal regulation of nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by Th1 and Th2 cytokines.
Eur. J. Immunol., 25, 1101-1104.
MOKRZYCKA, M., KOLASA, A., KOSIERKIEWICZ, A., WISZNIEWSKA, B. (2010):
Inducible nitric oxide synthase in duodenum of children with Giardia lamblia infection.
Folia Histochem. Cytobiol., 48, 191-196.
MONCADA, S., HIGGS, A. (1993):
The L-arginine nitric oxide pathway.
N. Engl. J. Med., 329, 2002-2012.
MORRIS, S., M., BILLIAR, T. R. (1994):
New insights into the regulation of inducible nitric oxide synthesis.
Am. J. Physiol., 266, E829-839.
MOWAT, A.M. (2003):
Anatomical basis of tolerance and immunity to intestinal antigens.
Nat. Rev. Immunol., 3, 331-41.
MÜHL, H., BACHMANN, M., PFEILSCHIFTER, J. (2011):
Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity.
Cell. Microbiol., 13, 340-348.
MÜNSTER, M., HÖRAUF, A., BILZER, T. (2006):
Bestimmung des Krankheitsschweregrades und des Ergebnisses diätetischer,
antibiotischer und immunsuppressiver Interventionen durch Anwendung des caninen IBD Aktivitätsindex bei 21 Hunden mit chronisch entzündlicher Darmkrankheit.
Berl. Münch. Tierärztl. Wochenschr. 119, 493-505.
MURPHY, K., TRAVERS, P., WALPORT, M. (2009):
Janeway Immunologie. 7. Aufl.
Spektrum Akademischer Verlag, Heidelberg, S. 53-193.
NAITO, Y., TAKAGI, T., OKADA, H. et al. (2008):
Expression of inducible nitric oxide synthase and nitric oxide-modified proteins in Helicobacter pylori-associated atrophic gastric mucosa.
J. Gastroenterol. Hepatol., 23, 250-257.
NATHAN, C. (1992):
Nitric oxide as a secretory product of mammalian cells.
FASEB J., 6, 3051-3064.
Literaturverzeichnis 115
NATHAN, C., QIAO-WEN, X. (1994):
Nitric oxide synthases: roles, tolls, and controls.
Cell, 78, 915-918.
NISHIKAWA, M., KAKEMIZU, N. ITO, T., KUDO, M., KANEKO, T., SUZUKI, M., UDAKA, M., IKEDA, H., OKUBO, T. (1999):
Superoxide mediates cigarette smoke-induced infiltration of neutrophils into the airways through nuclear factor-kappaB activation and IL-8 mRNA expression in guinea pigs in vivo.
Am. J. Resp. Cell. Mol. Biol., 20, 189-198.
NUMATA, M., SHUNSUKE, S., MIYAZAWA, N., MIYASHITA, A., NAGASHIMA, Y., INOUE, S., KANEKO, T., OKUBO, T. (1998):
Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs.
J. Immunol., 160, 3031-3037.
ORTOLANI, C., PASTORELLO, E. A. (2006):
Food allergies and food intolerances.
Best Pract. Res. Clin. Gastroenterol., 20, 467-83.
PACKEY, S. D., SARTOR, R. B. (2008):
Interplay of commensal and pathogenic bacteria, genetic mutations, and
immunoregulatory defects in the pathogenesis of inflammatory bowel diseases.
J. Int. Med., 263, 597-606.
PAYNE, D., KUBES, P. (1993):
Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability.
Am. J. Physiol., 265, G189-G195.
PEREZ, L.-H., BUTLER, M., CREASEY, T., DZINK-FOX, J., GOUNARIDES, J., PETIT, S., ROPENGA, A., RYDER, N., SMITH, K., SMITH, P., PARKINSON, S. J.
(2010):
Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn´s disease-associated mutations.
PloS ONE, 5, 10915.
PERNER, A., RASK-MADSEN, J. (1999):
Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders.
Aliment. Pharmacol. Ther., 13, 135-144.
PETERS, I. R., HELPS, C. R., CALVERT, E. L., HALL, E. J., DAY, M. J. (2005):
Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction.
J. Vet. Intern. Med., 19, 644-653.
QUIGLEY, P.J., HENRY, K. (1981):
Eosinophilic enteritis in the dog: A case report with a brief review of the literature.
J. Comp. Pathol., 91, 387-392.
RADI, Z. A., CAVERLY, J. M., DIXON, R. A., BROGDEN, K. A., ACKERMANN, M. R.
(2001):
Effects of the synthetic selection inhibitor TBC1269 on tissue damage during acute Mannheimia haemolytica-induced pneumonia in neonatal calves.
Am. J. Vet. Res., 62, 17-22.
RAMIRO-PUIG, E., PÉREZ-CANO, F. J., CASTELLOTE, C., FRANCH, A., CASTELL, M. (2008):
The bowel: A key component of the immune system.
Rev. Esp. Enferm. Dig., 100, 29-34.
RIDYARD, A. E., NUTTALL, T. J., ELSE, R. W., SIMPSON, J. W., MILLER, H. R.
(2002):
Evaluation of th1, th2 and immunosuppressive cytokine mRNA expression within the colonic mucosa of dogs with idiopathic lymphocytic-plasmacytic colitis.
Vet. Immunol. Immunopathol., 86, 205-214.
ROBERTS, P. J., RILEY, G. P., MORGAN, K., MILLER, R., HUNTER, J. O., MIDDLETON, S. J. (2001):
The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon.
J. Clin. Pathol., 54, 293-297.
RODRIGUEZ, A., RODRIGUEZ, F., PENA, L., FLORES, J.M., GONZALES, M., CASTANO, M. (1995):
Eosinophilic gastroenteritis syndrome in a dog.
Vet. Q., 17, 34-36.
ROEDIGER, W. E., LAWSON, M. J., NANCE, S. H., RADCLIFFE, B. C. (1986):
Detectable colonic nitrite levels in inflammatory bowel disease – mucosal or bacterial malfunction?
Digestion., 35, 199-204.
ROTH, L., WALTON, A.M., LEIB, M.S., BURROWS, C.F. (1990):
A grading system for lymphocytic plasmacytic colitis in dogs.
J. Vet. Diagn. Invest., 2, 257-262.
SANDER, C. H., LANGHAM, R. F. (1968):
Canine histiocytic ulcerative colitis – a condition resembling Whipple´s disease, colonic histiocytosis, and Malakoplakia in man.
Arch. Pathol., 85, 94-100.
Literaturverzeichnis 117
SANSONETTI, P. J. (2004):
War and peace at mucosal surfaces.
Nat. Rev. Immunol., 4, 953-964.
SCHMITZ, S., GARDEN, O. A., WERLING, D., ALLENSPACH, K. (2012):
Gene expression of selected signature cytokines of T cell subsets in duodenal tissues of dogs with and without inflammatory bowel disease.
Vet. Immunol. Immunopathol., 146, 87-91.
SCHÖLMERICH, J. (1999):
Inflammatory Bowel Disease.
Endoscopy, 31, 66-73.
SCHREINER, N. M. S., GASCHEN, F., GRÖNE, A., SAUTER, S. N., ALLENSPACH, K. (2008):
Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies.
J. Vet. Intern. Med., 22, 1079-1083.
SCHUMMER, A. u. WILKENS, H. (1995):
Verdauungsapparat, Rumpfdarm.
In: K.-H. Habermehl, B. Vollmerhaus u. H. Wilkens (Hrsg.): Lehrbuch der Anatomie der Haustiere. 7. Aufl.
Blackwell Wissenschaftsverlag, Berlin, Bd. 2, S. 100-118.
SHI, D., DAS, J., DAS, G. (2006):
Inflammatory bowel disease requires the interplay between innate and adaptive immune signals.
Cell Res., 16, 70-74.
SICHERER, S. H., SAMPSON, H. A. (2010):
SICHERER, S. H., SAMPSON, H. A. (2010):